Secretary for Health Prof Lo Chung-mau attended the 13th Nanjing Academic Symposium on Hepatobiliary Surgery & Liver Transplantation in Nanjing today to share with liver transplant experts from around the world Hong Kong's latest developments in organ transplantation, and the work of the Hong Kong Special Administrative Region Government in co-operation with the Mainland on organ donation and transplantation.
 
In his address at the opening ceremony, Prof Lo said: “Hong Kong and the Mainland have a long-standing collaboration in hepatobiliary surgery. I have personally witnessed experts from both places jointly performing a number of complex liver transplant surgeries, achieving in-depth integration of technology and resources, which is an exemplary model of medical co-operation under the 'one country, two systems' framework.

“In recent years, Hong Kong and the Mainland have also made breakthroughs in organ donation and transplantation. In December 2022 and February this year, two cases of cross-boundary heart donation successfully saved the lives of two infants, exemplifying to the fullest the inseparable ties between the Mainland and Hong Kong as well as our shared principle and mission in protecting and saving lives.”
 
Apart from stressing that with the accumulation of experience, the channels and procedures for handling urgent cross-boundary organ transplant requests have now been streamlined and standardised, Prof Lo made it clear that the Hong Kong SAR Government will continue to explore arrangements for regularising this mechanism.
 
He also shared the latest developments in the prevention and control of liver disease in Hong Kong.
 
“Since 1988, Hong Kong has provided universal hepatitis B vaccination for all newborns, significantly reducing infection rates among younger generations.
 
“As outlined in last year's Policy Address, the Chief Executive also proposed to implement hepatitis B screening to prevent liver cancer. If patients can be identified at an early stage, it will facilitate early identification and early treatment, thereby effectively reducing risks of developing complications including cirrhosis and liver cancer.”
 
Prof Lo then visited the Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), where he exchanged views and shared experiences on enhancing hospital management and services with the hospital's President Prof Liu Yun.
 
He highlighted that the Hospital Authority is adopting China's International Hospital Accreditation Standards (2021 Version) developed by the Shenzhen Hospital Accreditation Research Centre to resume the hospital accreditation programme at its public hospitals.
 
Moreover, the authority seeks to optimise the diagnosis process of the relevant specialties and improve the treatment outcomes through the establishment of the first stroke centre at Tuen Mun Hospital, as well as chest pain centres at both Queen Mary Hospital and Prince of Wales Hospital.
 
Prof Lo added that the Hong Kong SAR Government will continue to promote the accreditation programme under the standards as well as the establishment of chest pain centres and stroke centres.
 
“These initiatives will not only improve healthcare integration within the Guangdong-Hong Kong-Macao Greater Bay Area and support Hong Kong's integration into national development, but also leverage Hong Kong's advantages of enjoying strong support of the motherland and being closely connected to the world, so as to demonstrate the excellence of the national hospital accreditation standards to the international community.”